Lincoln International’s Global Healthcare Group Announces Record Year
Lincoln International remains one of the most active healthcare M&A advisors in 2021
Lincoln International’s global healthcare mergers and acquisitions (M&A) activity in 2021 eclipsed that of 2020 led by the firm’s growing sector capabilities and strong appetite for deals. In 2021, we completed transactions with or on behalf of some of the largest and most well-known names in healthcare private equity. Lincoln’s reputation for advising on, executing and closing high-quality assignments across healthcare services, life sciences, pharma outsourcing, medical products and healthcare information technology (IT) continues to strengthen. Lincoln is one of the only investment banks with dedicated, senior healthcare bankers covering markets across the Americas, Europe and Asia.
Lincoln International's global Healthcare Group celebrates record results in 2021.
Select Notable 2021 Healthcare Transactions
Lincoln International is pleased to announce that ARK Agency has been sold to OPEN Health, a portfolio company of Amulet Capital Partners
Lincoln International advised Pharmarack Technologies in its sale to DigiHealth Technologies LLP
Lincoln International is pleased to announce MedTest Holdings, a portfolio company of Enhanced Healthcare Partners, has been sold to HORIBA
Lincoln International advised Harbour Group on the sale of SP Industries to ATS Automation Tooling Systems
Lincoln International is pleased to announce that KIMS Hospital has been sold to LycaHealth
Lincoln International advised Bond Vet in the receipt of a significant investment from Warburg Pincus
Lincoln international is pleased to announce that Novozymes (CPSE:NZYM B) has acquired a majority stake in Synergia Life Sciences
Lincoln International advised on the sale of Caring Brands International, a portfolio company of Levine Leichtman Capital Partners, to Wellspring Capital Management
Lincoln International is pleased to announce that it has advised the founders and shareholders of KMK Kinderzimmer on the sale of a majority stake to Franz Haniel & Cie.
Lincoln International advised New Harbor Capital on the sale of Wedgewood Pharmacy to Partners Group
Lincoln International is pleased to announce that it has advised H&T Presspart on the acquisition of novelex AG from Liberta Partners
Real Deals | Healthcare M&A Resilience
What trends have you seen in the last quarter in relation to valuations in the healthcare space? Matthew Lee: It’s early days to get an accurate read on valuations as… Read More
Lincoln International Announces Strategic Partnership with Australian Corporate Advisory Firm, Miles Advisory Partners
Lincoln International, a global investment banking advisory firm, announced today that it has established a strategic partnership with Miles Advisory Partners, an Australian-based independent corporate advisory firm, servicing the robust… Read More
Lincoln International’s Global Healthcare Group Announces Strong Results in 2022
Lincoln International’s global Healthcare Group enjoyed another consecutive year of record-setting mergers and acquisitions (M&A) deal volume, average deal size and a record backlog heading in to 2023. Our performance… Read More
Scrip | What Does 2023 Hold for Biopharma? Part 6: Artificial Intelligence
Originally posted by Scrip on February 10, 2023. Tony Crisman, Managing Director in Lincoln’s Healthcare Group, shares his predictions for artificial intelligence in the biopharma industry. View the original article.
Meet Our Senior Team
I enjoy working closely with clients to overcome challenging situations and to develop strategies to meet their business goals.
Managing Director | Management Board MemberFrankfurt